Free Trial Corporate Access


Global Investor Magazine Copying and distributing are prohibited without permission of the publisher
Email a friend
  • Please enter a maximum of 5 recipients. Use ; to separate more than one email address.


BNY Mellon hires three senior executives

17 June 2014


New positions added to HedgeMark team

Read more: BNY Mellon HedgeMark

BNY Mellon has created three new senior executive positions in its dedicated managed accounts provider team, HedgeMark.

The firm has hired Bill Santos as global head of business development, Maxine Alexis as head of the legal consulting group and Neil Novembre as head of fund accounting.

"We’ve seen increased demand in the institutional marketplace for our services, and Santos, Alexis and Novembre’s specialised expertise will be integral to our growth," said Andrew Lapkin, CEO of HedgeMark.

"They bring considerable experience in the managed account business, and we’re excited about adding such talented industry veterans to our team."

Santos will be responsible for global business development, marketing, and relationship management. Alexis will oversee all legal matters relating to the structuring and operation of HedgeMark’s dedicated managed account (DMA) solution, while Novembre will oversee fund accounting operations for DMA.

In February, BNY Mellon announced an agreement to acquire its remaining ownership interest in HedgeMark. The deal was completed in early May.

Santos joins HedgeMark from Kenmar Olympia Group where he was senior managing director and head of institutional business development for the Americas and Japan.

Alexis joins from Deutsche Bank where she was a senior legal counsel and most recently served as global co-head of Deutsche Bank’s alternatives legal practice group.

Novembre served as chief financial officer of DB Advisors Hedge Fund Group, responsible for their fiduciary business of domestic and offshore funds and managed accounts.


Have your say
  • All comments are subject to editorial review.
    All fields are compulsory.